[Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy].

Molekuliarnaia biologiia

Volumn 45, Issue 6, 2011, Pages 963-972

  Tsareva, E I ^a   Kulakova, O G ^a   Makarycheva, O I ^a   Boiko A N ^a   Shchur, S G ^a   Lashch, N I ^a   Popova, N F ^a   Gusev, E I ^a   Bashinskaia, V V ^a   L'vov, D V ^a   Favorov, A V ^a   Ochs, M F ^a   Favorova, O O ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CHEMOKINE RECEPTOR CCR5; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLATIRAMER; HLA DRB1 ANTIGEN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 7 RECEPTOR ALPHA; PEPTIDE; PHARMACOLOGICAL BIOMARKER; TNF PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETICS; HUMAN; MULTIPLE SCLEROSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADJUVANTS, IMMUNOLOGIC; BIOMARKERS, PHARMACOLOGICAL; CTLA-4 ANTIGEN; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HLA-DRB1 CHAINS; HUMANS; INTERFERON-BETA; INTERFERON-GAMMA; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MULTIPLE SCLEROSIS; PEPTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR5; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873021372     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)